正科医药 (836342.OC)

+ 收藏

现金流量表(正科医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 126,483,202.30195,332,764.7389,291,277.19203,859,915.1999,005,738.98
 收到其他与经营活动有关的现金(元) 146,944.121,051,809.75171,324.031,503,791.87966,639.73
 经营活动现金流入小计(元) 126,630,146.42196,384,574.4889,462,601.22205,363,707.0699,972,378.71
 购买商品、接受劳务支付的现金(元) 32,180,390.9654,972,751.0425,859,083.4948,512,300.7211,602,215.94
 支付给职工以及为职工支付的现金(元) 27,285,980.8445,703,744.5621,232,753.1239,020,793.5716,622,262.23
 支付的各项税费(元) 10,074,153.7819,345,164.0712,990,913.6114,988,631.706,354,653.80
 支付其他与经营活动有关的现金(元) 17,928,072.0637,253,113.8714,348,394.4258,117,005.3549,358,832.74
 经营活动现金流出小计(元) 87,468,597.64157,274,773.5474,431,144.64160,638,731.3483,937,964.71
 经营活动产生的现金流量净额(元) 39,161,548.7839,109,800.9415,031,456.5844,724,975.7216,034,414.00
二、投资活动产生的现金流量
 收回投资收到的现金(元) 17,700,000.0053,800,000.0020,613,362.09128,150,000.0064,364,583.61
 取得投资收益收到的现金(元) 41,804.63209,873.31-421,788.47-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 108,000.0048,000.0047,127.96--
 投资活动现金流入小计(元) 17,849,804.6354,057,873.3120,660,490.05128,571,788.4764,364,583.61
 购建固定资产、无形资产和其他长期资产支付的现金(元) 24,535,060.2430,982,336.7015,880,896.0719,382,947.849,444,172.28
 投资支付的现金(元) 27,200,000.0043,800,000.0014,000,000.00126,600,000.0067,500,000.00
 投资活动现金流出小计(元) 51,735,060.2474,782,336.7029,880,896.07145,982,947.8476,944,172.28
 投资活动产生的现金流量净额(元) -33,885,255.61-20,724,463.39-9,220,406.02-17,411,159.37-12,579,588.67
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 25,500,000.0066,415,000.0047,415,000.0069,030,000.0031,050,000.00
 筹资活动现金流入小计(元) 25,500,000.0066,415,000.0047,415,000.0069,030,000.0031,050,000.00
 偿还债务支付的现金(元) 23,460,000.0070,955,000.0035,245,000.0061,580,000.0032,600,000.00
 分配股利、利润或偿付利息支付的现金(元) 359,748.5012,527,748.8212,066,554.3528,386,586.87334,563.75
 支付其他与筹资活动有关的现金(元) 1,394,877.853,717,249.061,662,299.222,074,171.501,440,877.50
 筹资活动现金流出小计(元) 25,214,626.3587,199,997.8848,973,853.5792,040,758.3734,375,441.25
 筹资活动产生的现金流量净额(元) 285,373.65-20,784,997.88-1,558,853.57-23,010,758.37-3,325,441.25
五、现金及现金等价物净增加额(元) 5,561,666.82-2,399,660.334,252,196.994,303,057.98129,384.08
 加:期初现金及现金等价物余额(元) 5,150,900.337,550,560.667,550,560.663,247,502.683,247,502.68
 期末现金及现金等价物余额(元) 10,712,567.155,150,900.3311,802,757.657,550,560.663,376,886.76
补充资料:
 净利润(元) 32,897,039.3724,864,516.3123,351,627.0135,537,246.7517,730,536.15
 资产减值准备(元) -357,166.18176,894.691,289,773.32166,115.53187,185.58
 固定资产和投资性房地产折旧(元) 3,965,795.127,685,007.923,772,865.166,856,708.344,396,272.03
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 3,965,795.127,685,007.923,772,865.166,856,708.344,396,272.03
 无形资产摊销(元) 3,920,786.065,977,718.992,027,968.772,066,479.871,688,432.30
 长期待摊费用摊销(元) 796,293.101,558,709.15781,045.941,414,051.03661,318.09
 处置固定资产、无形资产和其他长期资产的损失(元) -8,971.03-10,167.19-10,227.19--
 固定资产报废损失(元) 9,484.2160,022.8911,185.6682,492.5147,062.38
 公允价值变动损失(元) -49,901.19--6,484.72-20,989.83-245,848.61
 财务费用(元) 423,662.531,101,565.77547,850.251,038,269.26503,949.67
 投资损失(元) -41,804.63-188,883.48-92,372.26-344,972.47-
 递延所得税(元) 1,022,875.59-2,526,110.77809,023.503,393,328.131,198,154.98
  其中:递延所得税资产减少(元) 1,023,757.90-2,526,993.08809,023.503,393,328.131,198,154.98
 递延所得税负债增加(元) -882.31882.31---
 存货的减少(元) -11,914,134.472,925,320.271,385,653.37-6,695,568.35-2,586,421.76
 经营性应收项目的减少(元) -16,806,222.598,004,300.21-701,077.19-10,165,734.26-3,035,433.99
 经营性应付项目的增加(元) 21,163,677.76-13,749,494.44-19,467,305.228,624,561.58-4,801,044.84
 其他(元) 1,119,688.771,306,303.55186,614.80--
 现金的期末余额(元) 10,712,567.155,150,900.3311,802,757.657,550,560.663,376,886.76
 减:现金的期初余额(元) 5,150,900.337,550,560.667,550,560.663,247,502.683,247,502.68
 现金及现金等价物的净增加额(元) 5,561,666.82-2,399,660.334,252,196.994,303,057.98129,384.08
公告日期 2024-08-282024-04-252023-08-282023-04-282022-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院